Trial Profile
Cilengitide (EMD 121974) (IND 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cilengitide (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma
- Focus Therapeutic Use
- 24 Jul 2013 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 24 Jul 2013 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 13 Nov 2012 Status changed from completed to suspended as reported by ClinicalTrials.gov (NCT00679354).